During the past decade, Medanta-The Medicity conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 19 clinical trials were completed, i.e. on average, 67.9% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 12 clinical trials were completed. i.e. 120% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Medanta-The Medicity" #1 sponsor was "Medtronic Cardiac Rhythm and Heart Failure" with 7 trials, followed by "Abbott Medical Devices" with 6 trials sponsored, "Boehringer Ingelheim" with 3 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored and "Hoffmann-La Roche" with 3 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Medanta-The Medicity" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator, "Indian Society of Critical Care Medicine" with 1 trials as a collaborator and "Iqvia Pty Ltd" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Medanta-The Medicity" are "Congestive Heart Failure" (4 trials), "Coronary Artery Disease" (3 trials), "Heart Failure" (3 trials), "Atrial Fibrillation" (2 trials) and "Pulmonary Arterial Hypertension" (2 trials). Many other conditions were trialed in "Medanta-The Medicity" in a lesser frequency.

Most popular intervention types in "Medanta-The Medicity" are "Drug" (18 trials), "Device" (13 trials), "Other" (6 trials), "Biological" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Baricitinib" (2 trials), "Empagliflozin" (2 trials), "ABSORB BVS" (1 trials) and "Aspirin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Medanta-The Medicity" are 41 trials for "All" genders.

Currently, there are NaN active trials in "Medanta-The Medicity". undefined are not yet recruiting, 6 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in Medanta-The Medicity, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Medanta-The Medicity, 3 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 12 trials that are defined as “Not Applicable".